• Atrial Natriuretic Peptide: Assay Design Guide

  2026-09-28

  A practical, mechanistic guide to Atrial Natriuretic Peptide assays, with special attention to ANP fragment identity, cardiovascular endpoints, and causal experimental design. It also explains how an adiponectin neuroinflammation study can improve—not replace—ANP-based cardiovascular research workflows.

• Safe DNA Gel Stain for DNA-Driven Cell Models

  2026-09-28

  Safe DNA Gel Stain supports nucleic-acid quality control in DNA-based biomimetic motility research. This article connects gel-based construct verification to the interpretation of multivalent vesicle crawling—while clarifying what staining can and cannot establish.

• Foretinib: Separating Growth Arrest from Cell Killing

  2026-09-27

  Foretinib (GSK1363089) can reduce tumor-cell signals through more than one biological route: slowing proliferation, promoting cell death, and disrupting motility. This guide applies a key distinction from cancer drug-response research to Foretinib experiments, helping researchers choose readouts that reveal what an apparent response actually means.

• Entecavir (BMS200475): HBV Research Workflows

  2026-09-26

  Build reproducible HBV replication assays with Entecavir (BMS200475), from DMSO stock preparation to viral DNA and viability readouts. A resistance-aware workflow helps distinguish antiviral response in treatment-naïve and lamivudine-resistant models while keeping assay findings in the right clinical context.

• TCAIM Tunes OGDH to Regulate Mitochondrial Metabolism

  2026-09-25

  A 2025 Molecular Cell study identifies the mitochondrial DNAJC co-chaperone TCAIM as a selective OGDH-binding factor that promotes lower OGDH protein levels through HSPA9 and LONP1. The resulting reduction in OGDH complex activity changes carbohydrate catabolism, revealing a proteostasis-based route for regulating mitochondrial metabolism.

• 7-AAD Cell Viability Assay Kit: Practical Guide

  2026-09-25

  Learn how the 7-AAD Cell Viability Assay Kit (SKU K2235) can support membrane-integrity measurements in flow cytometry, microscopy, and multiplex apoptosis workflows. This scenario-driven guide covers assay design, controls, interpretation, protocol parameters, and evidence-conscious product selection.

• CD44 Rewires Metabolism in IDH-Mutant Leukemia

  2026-09-24

  The study identifies CD44 as a metabolic dependency in IDH-mutant leukemia: it redirects glucose metabolism to sustain NADPH and R-2-hydroxyglutarate production. Its isogenic-cell design supports a mechanistic link between mutant IDH and CD44, while combination experiments point to a potential vulnerability that merits further testing alongside mutant-IDH inhibition.

• UK-5099 Workflows for Mitochondrial Immunometabolism

  2026-09-24

  Use UK-5099 to test how mitochondrial pyruvate entry contributes to cellular energy readouts and stimulated cytokine responses. This practical workflow adapts standardized whole-blood stimulation while distinguishing pathway-specific evidence from exploratory immune effects.

• LMO2–LDB1 Signaling in AML: Study Findings

  2026-09-23

  The study links LMO2 with the transcriptional co-regulator LDB1 in acute myeloid leukemia (AML), combining protein-interaction evidence with perturbation and gene-regulation analyses. Its findings support a role for LDB1 in AML-cell survival and proliferation and suggest that LMO2 contributes to this program, while leaving therapeutic relevance to be tested.

• Indazole Glucagon Receptor Antagonists: Study Insights

  2026-09-23

  Lin and colleagues reported a new indazole-, indole-, and azaindole-based series of glucagon receptor antagonists derived from the MK-0893 program. Their structure–activity relationship study produced compounds with strong in vitro activity, favorable rat pharmacokinetics, and oral glucose-lowering activity in humanized glucagon receptor mouse models.

• ECL Chemiluminescent Substrate Detection Kit Guide

  2026-09-22

  Learn how the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), SKU K1231, can strengthen mechanistic immunoblotting alongside cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers membrane compatibility, signal optimization, interpretation, and practical product selection using documented performance characteristics and relevant ferroptosis research.

• 5-Azacytidine: Workflow for DNA Demethylation

  2026-09-22

  Build reproducible 5-Azacytidine experiments that connect DNMT inhibition with promoter methylation, gene reactivation, and cancer-cell phenotypes. The workflow adapts the HNF4A gastric-cancer findings into practical controls while preserving applications in leukemia and multiple myeloma research.

• LEE011 succinate: CDK4/6 Assay Workflows

  2026-09-21

  Build more informative CDK4/6 experiments with LEE011 succinate by combining proliferation, cell-cycle, and time-course readouts. This guide connects practical formulation and dosing choices with a dynamic biomarker concept from prostate cancer research while clearly separating evidence from assay-development recommendations.

• Cabazitaxel (XRP6258): Practical Lab Guide

  2026-09-21

  Cabazitaxel (XRP6258, SKU B2157) is a water-insoluble semi-synthetic taxane derivative for studying antiproliferative responses and microtubule dynamics disruption, including taxane-resistant models. It should be prepared in DMSO or ethanol, used promptly, and excluded from water-only assays unless a separately validated formulation is available.

• IWP-2 Wnt Production Inhibitor: Applied Workflows

  2026-09-20

  IWP-2 is an upstream Wnt production inhibitor for separating ligand-dependent signaling from downstream cellular effects. This guide connects Porcupine inhibition with practical MKN28 proliferation, migration, transcriptional, and apoptosis workflows while emphasizing formulation control and cell-state-aware interpretation.

7943 records 1/530 page Next 12345 下5页 Last page